oxyquinoline has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Oxyquinoline: An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.
quinolin-8-ol : A monohydroxyquinoline that is quinoline substituted by a hydroxy group at position 8. Its fungicidal properties are used for the control of grey mould on vines and tomatoes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cámara-Sánchez, P | 1 |
| Díaz-Riascos, ZV | 1 |
| García-Aranda, N | 1 |
| Gener, P | 1 |
| Seras-Franzoso, J | 1 |
| Giani-Alonso, M | 1 |
| Royo, M | 1 |
| Vázquez, E | 1 |
| Schwartz, S | 1 |
| Abasolo, I | 1 |
1 other study available for oxyquinoline and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Humans; Mice; Neoplastic Stem Cells; Niclosamide; Oxy | 2022 |